Earnings Feed
Start Free
Home/Filings/4/0000899243-21-018932
4//SEC Filing

LEVIN MARK J 4

Accession 0000899243-21-018932

CIK 0001549595other
View on SEC.govCompany Profile

Filed

May 9, 8:00 PM ET

Accepted

May 10, 4:41 PM ET

Size

17.4 KB

Accession

0000899243-21-018932

Insider Transaction Report

Form 4
Period: 2021-05-06
Nurix Therapeutics, Inc.NRIX
Third Rock Ventures GP III, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-06−1,085,784→ 3,422,549 total
Holdings

  • Common Stock

    (indirect: See footnote)
    86,799

  • Common Stock

    (indirect: See footnote)
    86,798

  • Common Stock

    (indirect: See footnote)
    78,118

  • Common Stock

    (indirect: See footnote)
    8,677
LEVIN MARK J
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-06−1,085,784→ 3,422,549 total
Holdings

  • Common Stock

    (indirect: See footnote)
    8,677

  • Common Stock

    (indirect: See footnote)
    86,799

  • Common Stock

    (indirect: See footnote)
    78,118

  • Common Stock

    (indirect: See footnote)
    86,798
Third Rock Ventures III, L.P.
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-06−1,085,784→ 3,422,549 total
Holdings

  • Common Stock

    (indirect: See footnote)
    86,798

  • Common Stock

    (indirect: See footnote)
    86,799

  • Common Stock

    (indirect: See footnote)
    78,118

  • Common Stock

    (indirect: See footnote)
    8,677
TRV GP III, LLC
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-06−1,085,784→ 3,422,549 total
Holdings

  • Common Stock

    (indirect: See footnote)
    78,118

  • Common Stock

    (indirect: See footnote)
    86,799

  • Common Stock

    (indirect: See footnote)
    8,677

  • Common Stock

    (indirect: See footnote)
    86,798
TEPPER ROBERT I
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-06−1,085,784→ 3,422,549 total
Holdings

  • Common Stock

    (indirect: See footnote)
    8,677

  • Common Stock

    (indirect: See footnote)
    86,799

  • Common Stock

    (indirect: See footnote)
    78,118

  • Common Stock

    (indirect: See footnote)
    86,798
STARR KEVIN P
10% Owner
Transactions
  • Other

    Common Stock

    2021-05-06−1,085,784→ 3,422,549 total
Holdings

  • Common Stock

    (indirect: See footnote)
    86,799

  • Common Stock

    (indirect: See footnote)
    78,118

  • Common Stock

    (indirect: See footnote)
    86,798

  • Common Stock

    (indirect: See footnote)
    8,677
Footnotes (6)
  • [F1]Pursuant to a 10b5-1 trading plan adopted on October 29, 2020 by Third Rock Ventures III, L.P. ("TRV III"), TRV III distributed for no consideration, 1,085,784 shares of Common Stock of the Issuer (the "Shares") on May 6, 2021 to its limited partners and to Third Rock Ventures GP III, L.P. ("TRV GP III"), the general partner of TRV III, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP III distributed, for no consideration, the Shares it received in the distribution by TRV III to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
  • [F2]These shares are directly held by TRV III. The general partner of TRV III is TRV GP III. The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
  • [F3]The shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.
  • [F4]The shares are directly held by Levin Family 2014 Irrevocable Trust. Includes Shares received in the distributions described in footnote (1) above.
  • [F5]The shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.
  • [F6]The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.

Documents

1 file

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

→
Entity typeother

Related Parties

1
  • filerCIK 0001180428

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 4:41 PM ET
Size
17.4 KB
View on SEC.gov